Related Experiment Video
Updated: Oct 8, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Naturally Occurring SGLT2 Inhibitors: A Review
Habib Yaribeygi1, Milad Ashrafizadeh2,3, Thozhukat Sathyapalan4
1Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran. habib.yari@yahoo.com.
Abstract:
With an increasing incidence of diabetes mellitus globally due to various factors, including unhealthy lifestyle, there is a need for developing novel drugs for the management of diabetes. This chronic metabolic disorder results in high blood glucose levels due to the body's inability to reduce the concentration of glucose. The decreased secretion of insulin and increased resistance to insulin action contribute to the development of diabetes mellitus. There have been efforts to target pathways involved in the metabolism of blood glucose. It seems that most of the currently applied antidiabetic medications are associated with unwanted side effects. Hence, it appears that plant-derived chemicals can be considered as potential candidates in the management of diabetes. Sodium-glucose cotransporter inhibitors (SGLT2i) are synthetic hypoglycemic medications approved for managing patients with diabetes in lowering blood glucose. SGLT2i reduces blood glucose concentration by enhancing its urinary excretion and inhibition of its absorption through the kidney. It has been demonstrated that some of the naturally occurring nutraceutical agents can imitate the action of SGLT2i and, consequently, diminish the level of blood glucose. At the present review, we have discussed the phytochemicals that act like SGLT2i to decrease blood glucose level.
Insights
Discover natural compounds that mimic SGLT2 inhibitors for diabetes management. This review explores phytochemicals that reduce blood glucose by inhibiting sodium-glucose cotransporter activity, offering a potential alternative to synthetic drugs.
Area of Science:
- Endocrinology
- Pharmacology
- Natural Product Chemistry
Background:
- Global rise in diabetes mellitus necessitates novel therapeutic strategies.
- Current antidiabetic drugs often have undesirable side effects.
- Plant-derived compounds show promise for diabetes management.
Purpose of the Study:
- To review phytochemicals with Sodium-glucose cotransporter inhibitor (SGLT2) like activity.
- To explore natural agents as potential alternatives for diabetes treatment.
Main Methods:
- Literature review of studies on phytochemicals and SGLT2 inhibition.
- Analysis of mechanisms by which natural compounds affect glucose metabolism.
Main Results:
- Certain nutraceutical agents exhibit SGLT2 inhibitory effects.
- Phytochemicals can reduce blood glucose levels through mechanisms similar to SGLT2 inhibitors.
Conclusions:
- Plant-derived compounds offer a potential avenue for developing new antidiabetic treatments.
- Further research into phytochemicals acting as SGLT2 inhibitors is warranted.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: Sulfonylureas

